Australia's largest stock trading and investment forum Australia's #1 stock forum

STL

0.00%

$1.90 stargroup limited

Agree whole heartedly with you Sharks and have like you have had...

First 83 Last

Share
Profile

Follow
1bmafish

289 Posts.

4

04/06/17

11:46

Post #: 25086516
Share

Originally posted by sharks37 ↑

rattle, I first came across STL at a investor roadshow early last year - April I think, it was the Techknow investors conference in Melbourne where Todd was promoting the company - I liked what I saw and based on that I did my homework and bought my initial stake within a few weeks.

Investor roadshows are a standard avenue for companies seeking to raise the profile of their business to the investor community. I have invested in some good stocks whose price never moves because management make zero effort to communicate to the investor community - whether it be ASX announcements, investor roadshows or whatever. They are very frustrating stocks to be invested in because you know they are good business but there's just no buying interest because nobody knows about them. I would always rather a stock I invest in have a good communication strategy to the market because that inevitably helps generate buying demand if they perform.

And as for focusing on the business to grow it rather than doing presentations I would say communication is a necessary part of any business just like admin - you can't just focus on the business' core activity without doing all the supportive functions.

Cheers, Sharks

Expand

Agree whole heartedly with you Sharks and have like you have had the same sort of experience. There needs to be a holistic approach to growing a company.
Not only focusing on a task of carrying out the business mechanical's but carrying out a supporting strategy to influence external interest and a wider audience of investors.
Thanks
Fish

STL Price at posting: 2.7¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

PL3

Patagonia looks to raise $2.15M for South American exploration and development